VARIZIG®

Products



VariZIG® (Varicella Zoster Immune Globulin (Human))


VariZIG® (Varicella Zoster Immune Globulin (Human)) is a hyperimmune that contains antibodies specific for the Varicella zoster virus, which causes the viral infection known as chickenpox. VariZIG is approved in Canada.

VariZIG is indicated for the prevention or reduction in severity of maternal infections within 4 days of exposure to the varicella zoster virus.

The following information is available in .pdf

Canadian Product Monographs:

English
French
 




VariZIG® Product Inquiries:


Canada
T: 1-855-VZV-2446
(1-855-898-2446)
Email: cs@saolrx.com
Aptevo BioTherapeutics LLC, Berwyn, PA 19312
VARIZIG® [Varicella Zoster Immune Globulin (Human)]and any and all Aptevo BioTherapeutics LLC Inc. brand, product, service and feature names, logos, and slogans are trademarks or registered trademarks of Aptevo BioTherapeutics LLC in the United States and/or other countries.